Trial intelligence / Profile preview

Evaluation of the effect of levothyroxine on benign thyroid nodule volume

IRCT2016092624021N2Phase 2Completed

Sponsor
Guilan University of Medical Sciences
Start
Sep 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of levothyroxine sodium in benign thyroid nodule, sponsored by Guilan University of Medical Sciences. Primary endpoint: Change in benign thyroid nodule volume. Started Sep 2016; status: completed.

02

Drugs

levothyroxine sodium
03

Conditions

benign thyroid nodule

Beyond the preview

Go deeper on IRCT2016092624021N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2016092624021N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call